Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Galectin Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying

Author: Lisa Levin | July 21, 2023 07:24am

The Dow Jones closed higher by more than 150 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Scott's Liquid Gold

  • The Trade: Scott's Liquid Gold-Inc. (OTC:SLGD) Director Daniel Roller acquired a total of 794,067 shares an average price of $0.33. To acquire these shares, it cost around $262,042.
  • What’s Happening: The company’s shares jumped around 82% over the past six months.
  • What Scott's Liquid Gold Does: Scott's Liquid Gold Inc develop, market, and sell high-quality, high-value household and personal care products.

Augusta Gold

  • The Trade: Augusta Gold Corp. (OTC:AUGG) Executive Chairman Richard Warke acquired a total of 5,000 shares at an average price of $0.80. The insider spent around $4,000.
  • What’s Happening: Augusta Gold recently said that it is advancing on its plan to complete a Feasibility Study at its 100% owned Reward Project.
  • What Augusta Gold Does: Augusta Gold Corp is an exploration-stage company. The company is primarily engaged in the acquisition and exploration of gold properties. It operates Bullfrog Project, located in Beatty town of Las Vegas, Nevada.

Galectin Therapeutics

  • The Trade: Galectin Therapeutics Inc. (NASDAQ:GALT) Director Kary Eldred acquired a total of 1,598 shares at an average price of $1.79. To acquire these shares, it cost around $2,854.
  • What’s Happening: Galectin Therapeutics posted a narrower-than-expected quarterly loss.
  • What Galectin Therapeutics Does: Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company.

Check This Out: Investor Sentiment Declines After Nasdaq Falls 2%

Don’t forget to check out our premarket coverage here

Earth Science Tech

  • The Trade: Earth Science Tech, Inc. (OTC:ETST) CEO Giorgio R Saumat acquired a total of 50,002 shares at an average price of $0.08. The insider spent $ $4,050 to buy those shares.
  • What’s Happening: Earth Science Tech named Gabrielle Schuster as Chief Financial Officer of the Company.
  • What Earth Science Tech Does: Earth Science Tech Inc is a diversified holding company. Currently, the company is focused on emerging prospects in the health and wellness industry.

Posted In: AUGG ETST GALT SLGD